International Journal of Homoeopathic Sciences

The recent development of Russia’s personalized Enteromix mRNA cancer vaccines is not just a technological breakthrough-it represents a shift in how we think about treating disease. Studies on AI-designed endogenous retroviral (ERV) vaccines and the precise timing of neoantigen delivery show that the success of treatment depends on addressing each patient’s unique biology. Interestingly, this idea is not new. Homeopathy has long emphasized the importance of treating the individual as a whole, considering their distinct symptoms and susceptibilities. What modern research is now demonstrating is that this principle of individualization has real, measurable value: therapies tailored to the individual work better. These parallels suggest that the future of medicine should embrace a truly patient-centered approach, and they highlight the need for more research exploring individualized treatment strategies across different medical disciplines.